Literature DB >> 31518551

High-throughput method for in process monitoring of 3-O-sulfotransferase catalyzed sulfonation in bioengineered heparin synthesis.

Lei Lin1, Yanlei Yu2, Fuming Zhang2, Xing Zhang3, Robert J Linhardt4.   

Abstract

Bioengineered heparin (BEH) offers a potential alternative for the preparation of a safer pharmacological heparin. Construction of in-process control assays for tracking each enzymatic step during bioengineered heparin synthesis remains a challenge. Here, we report a high-throughput sensing platform based on enzyme-linked immunosorbent assay (ELISA) and enzymatic signal amplification that allows the rapid and accurate monitoring of the 3-OST sulfonation in BEH synthesis process. The anticoagulant activity of target BEH was measured to reflect the degree of sulfonation by testing its competitive antithrombin (AT) binding ability. BEH samples with different sulfonation degrees show different AT protein binding capacity and thus changes the UV response to a different extent. This BEH-induced signal can be conveniently and sensitively monitored by the plate sensing system, which benefits from its high sensitivity brought in by the enzymatic signal amplification. Furthermore, modification convenience and mechanical robustness also ensure the stability of the test platform. This proposed strategy exhibits excellent analytical performance in both BEH activity analysis and 3-OST sulfonation evaluation. The simple and sensitive plate system shows great potential in developing on-chip, high-throughput methods for fundamental biochemical process research, drug discovery, and clinic diagnostics.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3-OST sulfonation; Antithrombin binding; Bioengineered heparin; ELISA

Year:  2019        PMID: 31518551      PMCID: PMC6768755          DOI: 10.1016/j.ab.2019.113419

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  13 in total

1.  2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity.

Authors:  Robert J Linhardt
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

2.  A pH-sensitive heparin-binding sequence from Baculovirus gp64 protein is important for binding to mammalian cells but not to Sf9 insect cells.

Authors:  Chunxiao Wu; Shu Wang
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.

Authors:  Guoyun Li; Bo Yang; Lingyun Li; Fuming Zhang; Changhu Xue; Robert J Linhardt
Journal:  Anal Biochem       Date:  2014-03-28       Impact factor: 3.365

4.  Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III.

Authors:  M Hernaiz; J Liu; R D Rosenberg; R J Linhardt
Journal:  Biochem Biophys Res Commun       Date:  2000-09-16       Impact factor: 3.575

5.  E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor.

Authors:  Zhenyu Wang; Mellisa Ly; Fuming Zhang; Weihong Zhong; Amy Suen; Anne Marie Hickey; Jonathan S Dordick; Robert J Linhardt
Journal:  Biotechnol Bioeng       Date:  2010-12-15       Impact factor: 4.530

Review 6.  Heparin and anticoagulation.

Authors:  Akihiro Onishi; Kalib St Ange; Jonathan S Dordick; Robert J Linhardt
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

7.  Nuclear magnetic resonance quantification for monitoring heparosan K5 capsular polysaccharide production.

Authors:  Zhenyu Wang; Zhenqing Zhang; Scott A McCallum; Robert J Linhardt
Journal:  Anal Biochem       Date:  2009-12-16       Impact factor: 3.365

Review 8.  Heparin-protein interactions.

Authors:  Ishan Capila; Robert J Linhardt
Journal:  Angew Chem Int Ed Engl       Date:  2002-02-01       Impact factor: 15.336

9.  The US regulatory and pharmacopeia response to the global heparin contamination crisis.

Authors:  Anita Y Szajek; Edward Chess; Kristian Johansen; Gyöngyi Gratzl; Elaine Gray; David Keire; Robert J Linhardt; Jian Liu; Tina Morris; Barbara Mulloy; Moheb Nasr; Zachary Shriver; Pearle Torralba; Christian Viskov; Roger Williams; Janet Woodcock; Wesley Workman; Ali Al-Hakim
Journal:  Nat Biotechnol       Date:  2016-06-09       Impact factor: 54.908

Review 10.  Lessons learned from the contamination of heparin.

Authors:  Haiying Liu; Zhenqing Zhang; Robert J Linhardt
Journal:  Nat Prod Rep       Date:  2009-01-19       Impact factor: 13.423

View more
  2 in total

Review 1.  Recent advances in biotechnology for heparin and heparan sulfate analysis.

Authors:  Meng Qiao; Lei Lin; Ke Xia; Jun Li; Xing Zhang; Robert J Linhardt
Journal:  Talanta       Date:  2020-06-14       Impact factor: 6.057

Review 2.  Advances in the preparation and synthesis of heparin and related products.

Authors:  Sultan N Baytas; Robert J Linhardt
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.